STEVEN KENNETH GALSON

Allopathic & Osteopathic Physicians|Preventive Medicine|Public Health & General Preventive Medicine THOUSAND OAKS, CA NPI 1386975993

General Payments — all program years on this page

$200,335.64

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $69,146.39 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
BioCryst Pharmaceuticals, Inc. $69,146.3917

By program year

Program yearAmountRecords
2021 $1,801.445
2022 $63,801.277
2023 $65,586.547
2024 $69,146.3917

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1117471438 BioCryst Pharmaceuticals, Inc. $67.19 04/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117471440 BioCryst Pharmaceuticals, Inc. $15,000.00 06/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117473816 BioCryst Pharmaceuticals, Inc. $15,000.00 03/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117473818 BioCryst Pharmaceuticals, Inc. $2,251.20 04/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117476268 BioCryst Pharmaceuticals, Inc. $32.84 06/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117476270 BioCryst Pharmaceuticals, Inc. $139.53 07/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117476272 BioCryst Pharmaceuticals, Inc. $22.94 09/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117476672 BioCryst Pharmaceuticals, Inc. $878.90 02/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117476674 BioCryst Pharmaceuticals, Inc. $15,000.00 12/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117477044 BioCryst Pharmaceuticals, Inc. $63.32 12/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117477480 BioCryst Pharmaceuticals, Inc. $108.66 01/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117477482 BioCryst Pharmaceuticals, Inc. $159.78 07/12/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117478738 BioCryst Pharmaceuticals, Inc. $15,000.00 09/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117479094 BioCryst Pharmaceuticals, Inc. $2,261.20 07/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117479936 BioCryst Pharmaceuticals, Inc. $72.05 03/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117480744 BioCryst Pharmaceuticals, Inc. $3,074.95 10/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117482070 BioCryst Pharmaceuticals, Inc. $13.83 12/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.